直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

James R. Barney

Federal Circuit Refines ‘Induced Infringement’ Theory to Revive Akamai and McKesson Suits

August 31, 2012

The AmLaw Litigation Daily

In a 6-5 en banc decision in favor of Finnegan client Akamai Technologies Inc., the Federal Circuit revived two patent infringement cases—one brought by Akamai against Limelight Networks Inc., and another by McKesson Corp. against Epic Systems Corp. “More significantly, the court rejected its prior rule that, to prevail on a theory of “induced infringement” of a method patent, a plaintiff must show that a single actor (besides the defendant) directly infringed all the steps covered by the patent. Now, inducement applies even when the steps recited in the patented method were performed by multiple parties.”  Finnegan partner Donald R. Dunner stated that, “decision is well-grounded in prior precedent and legislative history. Dunner added that the ruling is extraordinarily significant, in that it provides a clear vehicle to patent owners proving infringement, notwithstanding the fact that the infringing acts are divided between multiple parties.”

Related Practices

Global IP Enforcement, Litigation, and Trials

Related Industries

Electrical and Computer Technology

金融服務與商業系統

Related News

Commentary

New Appellate Opinion in Amazon Biometric Data Case May Signal ‘Narrowing’ Scope of BIPA Litigation, Experts Say

May 20, 2026

Award/Ranking

Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award

May 13, 2026

Press Release

Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination

May 11, 2026

Commentary

ITC Bars Import of Innoscience Chips Made Before Redesign

May 8, 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Press Release

Finnegan Enhances Its German and European IP Practice with Björn Kalbfus

April 30, 2026

Commentary

Supreme Court Takes Up Generic Drug Labeling Fight

April 29, 2026

Commentary

Permanent Injunction Granted to USA Weightlifting Inc., Enjoining Use of Protected Marks

April 24, 2026

Press Release

Pvtech Achieves Perfect Record at USPTO: Institution of All 10 of 10 Ex Parte Reexamination Petitions Against Patents Asserted by Jiaxing Super Lighting

April 24, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP